Nature Publishing Group, publisher of Nature, and other science journals and reference works
Nature
my account e-alerts subscribe register
   
Friday 10 July 2009
Journal Home
Current Issue
AOP
Archive
Download PDF
References
Export citation
Export references
Send to a friend
More articles like this

Letters to Nature
Nature 385, 653 - 656 (13 February 1997); doi:10.1038/385653a0

Interaction between the C. elegans cell-death regulators CED-9 and CED-4

Mona S. Spector*, Serge Desnoyers*, Daniel J. Hoeppner*† & Michael O. Hengartner*

* Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, New York 11724, USA
Graduate Program in Genetics, Department of Molecular Microbiology, SUNY at Stony Brook, Stony Brook, New York 11794, USA

Programmed cell death (apoptosis) is an evolutionarily conserved process used by multicellular organisms to eliminate cells that are not needed or are potentially detrimental to the organism1,2. Members of the Bcl-2 family of mammalian proteins are intimately involved in the regulation of apoptosis, but, their precise mechanism of action remains unresolved3–5. In Caenorhabditis elegans, the Bcl-2 homologue CED-9 prevents cell death by antagonizing the death-promoting activities of CED-3, a member of the Caspase family of death proteases, and of CED-4, a protein with no known mammalian homologue6–9. Here we show that CED-9 interacts physically with CED-4. Mutations that reduce or eliminate CED-9 activity also disrupt its ability to bind CED-4, suggesting that this interaction is important for CED-9 function. Thus, CED-9 might control C. elegans cell death by binding to and regulating CED-4 activity. We propose that mammalian Bcl-2 family members might control apoptosis in a similar way through interaction and regulation of CED-4 homologues or analogues.

  1. Ellis, R. E., Yuan, J. & Horvitz, H. R. Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7, 663−698 (1991). | Article | PubMed | ISI | ChemPort |
  2. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456−1462 (1995). | PubMed | ISI | ChemPort |
  3. Hacker, G. & Vaux, D. L. A sticky business. Curr. Biol. 5, 622−624 (1995). | Article | PubMed | ISI | ChemPort |
  4. Korsmeyer, S. J. Regulators of cell death. Trends Genet. 11, 101−105 (1995). | Article | PubMed | ISI | ChemPort |
  5. Chinnaiyan, A. M. & Dixit, V. M. The cell-death machine. Curr. Biol. 6, 555−562 (1996). | PubMed | ISI | ChemPort |
  6. Hengartner, M. O., Ellis, R. E. & Horvitz, H. R. C. elegans gene ced-9 protects cells from programmed cell death. Nature 356, 494−499 (1992). | Article | PubMed | ISI | ChemPort |
  7. Hengartner, M. O. & Horvitz, H. R. C. elegans cell death gene ced-9 encodes a functional homolog of mammalian proto-oncogene bcl-2. Cell 76, 665−676 (1994). | Article | PubMed | ISI | ChemPort |
  8. Yuan, J. & Horvitz, H. R. The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death. Development 116, 309−320 (1992). | PubMed | ISI | ChemPort |
  9. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M. & Horvitz, H. R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1beta converting enzyme. Cell 75, 641−652 (1993). | Article | PubMed | ISI | ChemPort |
  10. Hengartner, M. O. & Horvitz, H. R. Programmed cell death in C. elegans. Curr. Opin. Gen. Dev. 4, 581−586 (1994). | ChemPort |
  11. Horvitz, H. R., Shaham, S. & Hengartner, M. O. The genetics of programmed cell death in the nematode Caenorhabditis elegans. Cold Spring Harbor Symp. Quant. Biol. LIX, 377−385 (1994).
  12. Ellis, H. M. & Horvitz, H. R. Genetic control of programmed cell death in the nematode C. elegans. Cell 44, 817−829 (1986). | Article | PubMed | ISI | ChemPort |
  13. Alnemri, E. S. et al. Human ICE/CED-3 protease nomenclature. Cell 87, 171 (1996). | Article | PubMed | ISI | ChemPort |
  14. Shaham, S. & Horvitz, H. R. An alternatively spliced C. elegans ced-4 RNA encodes a novel cell death inhibitor. Cell 86, 201−208 (1996). | Article | PubMed | ISI | ChemPort |
  15. Nagata, S. Telling cells their time is up. Curr. Biol. 6, 1241−1243 (1996). | Article | PubMed | ISI | ChemPort |
  16. Hengartner, M. O. & Horvitz, H. R. Activation of C. elegans cell death protein CED-9 by an amino-acid substitution in a domain conserved in Bcl-2. Nature 369, 318−320 (1994). | Article | PubMed | ISI | ChemPort |
  17. Vaux, D. L., Weissman, I. L. & Kim, S. K. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 258, 1955−1957 (1992). | PubMed | ISI | ChemPort |
  18. Shaham, S. & Horvitz, H. R. Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities. Genes Dev. 10, 578−591 (1996). | PubMed | ISI | ChemPort |
  19. Chien, C. T., Bartel, P. L., Sternglanz, R. & Fields, S. The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc. Natl Acad. Sci. USA 88, 9578−9582 (1991). | PubMed | ChemPort |
  20. Farrow, S. & Brown, R. New members of the Bcl-2 family and their protein partners. Curr. Opin. Genet. Dev. 6, 45−49 (1996). | Article | PubMed | ISI | ChemPort |
  21. Chen-Levy, Z., Nourse, J. & Cleary, M. L. The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol. Cell. Biol. 9, 701−710 (1989). | PubMed | ChemPort |
  22. Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D. & Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334−336 (1990). | Article | PubMed | ISI | ChemPort |
  23. Krajewski, S. et al. Immnunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am. J. Pathol. 145, 1323−1336 (1994). | PubMed | ISI | ChemPort |
  24. Hockenbery, D. M., Oltvai, Z. N., Yin, X.-M., Milliman, C. L. & Korsmeyer, S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241−251 (1993). | Article | PubMed | ISI | ChemPort |
  25. Hunter, J. J., Bond, B. L. & Parslow, T. G. Functional dissection of the human Bcl-2 protein: sequence requirements for inhibition of apoptosis. Mol. Cell. Biol. 16, 877−883 (1996). | PubMed | ISI | ChemPort |
  26. Van Aelst, L., Joneson, T. & Bar-Sagi, D. Identification of a novel Rac 1-interacting protein involved in membrane ruffling. EMBO J. 15, 3778−3786 (1996). | PubMed | ChemPort |
  27. Van Aelst, L. Two hybrid analysis of Ras-Raf interactions. In Methods in Molecular Biology (Humana, Totowa, NJ, USA, in the press).
  28. Miller, J. H. Assay of beta-galatosidase. In Experiments in Molecular Genetics 352−355 (Cold Spring Harbor Eaboratory Press, Cold Spring Harbor, 1972).
  29. Muchmore, S. W. et al. X-ray and NMR structure of human Bcl-x1, an inhibitor of programmed cell death. Nature 381, 335−341 (1996). | Article | PubMed | ISI | ChemPort |



© 1997 Nature Publishing Group
Privacy Policy